- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Fatty Liver in United Kingdom
Total 4334 results
-
Nemours Children's ClinicCompletedObesity | Cardiovascular Disease | Nonalcoholic Fatty Liver DiseaseUnited States
-
NuSirt BiopharmaCompleted
-
Gilead SciencesCompletedNonalcoholic Steatohepatitis (NASH) | Nonalcoholic Fatty Liver Disease (NAFLD)United States, New Zealand
-
Sagimet Biosciences Inc.CompletedNon-Alcoholic Fatty Liver DiseaseChina, United States
-
Gannex Pharma Co., Ltd.CompletedHealthy | NAFLDUnited States
-
Sonic IncytesActive, not recruitingLiver Fibroses | Non-Alcoholic Fatty Liver Disease (NAFLD) | Non-Alcoholic Steatohepatitis (NASH) | Liver SteatosesUnited States
-
Arisaph Pharmaceuticals IncUnknownNonalcoholic SteatohepatitisUnited States
-
Children's Hospital Medical Center, CincinnatiCompletedObesity | Nonalcoholic Fatty Liver Disease | Nonalcoholic SteatohepatitisUnited States
-
University of Wisconsin, MadisonNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); GE... and other collaboratorsActive, not recruitingNon-Alcoholic Fatty Liver Disease | Non-alcoholic SteatohepatitisUnited States
-
Akero Therapeutics, IncRecruitingNASH/MASH | NAFLD/MASLDUnited States, Canada, Puerto Rico, Australia, India
-
PfizerCompleted
-
Duke UniversityUniversity of FloridaTerminatedInsulin Resistance | Nonalcoholic Fatty Liver DiseaseUnited States
-
Icahn School of Medicine at Mount SinaiNational Institutes of Health (NIH)CompletedNASH - Nonalcoholic Steatohepatitis | Steatosis of LiverUnited States
-
Tasly Biopharmaceuticals Co., Ltd.RecruitingNonalcoholic SteatohepatitisUnited States
-
Erchonia CorporationWithdrawnNonalcoholic SteatohepatitisUnited States
-
Enanta Pharmaceuticals, IncPharmaceutical Research AssociatesCompletedPresumptive NAFLDUnited States
-
Case Western Reserve UniversityAmerican College of GastroenterologyCompletedNonalcoholic SteatohepatitisUnited States
-
Keith D Lindor, M.D.Ajinomoto USA, INC.CompletedNonalcoholic SteatohepatitisUnited States
-
Brigham and Women's HospitalRecruitingObesity | Non-Alcoholic Fatty Liver Disease | Non-alcoholic SteatohepatitisUnited States
-
Boston UniversityGlaxoSmithKlineTerminatedFatty Liver | Non-alcoholic Fatty Liver DiseaseUnited States
-
Heather PattonAmerican College of GastroenterologyCompleted
-
Bird Rock Bio, Inc.Perspectum; ProSciento, Inc.CompletedNAFLDUnited States, Australia, Canada
-
GlaxoSmithKlineRecruitingNon-alcoholic Fatty Liver DiseaseUnited States
-
UNC Nutrition Research InstituteCompletedUtilizing Non-Invasive Fibroscan® Technology to Identify Genetic Markers for Fatty Liver ProgressionNon-alcoholic Fatty Liver DiseaseUnited States
-
National Institute of Diabetes and Digestive and...Completed
-
Emirates Health Services (EHS)Mayo ClinicCompletedObesity | Non-Alcoholic Fatty Liver DiseaseUnited Arab Emirates
-
Georgetown UniversityCompletedNonalcoholic SteatohepatitisUnited States
-
Mayo ClinicUniversity of Florida; Orphan MedicalCompleted
-
Milton S. Hershey Medical CenterRecruitingExercise | NASH - Nonalcoholic Steatohepatitis | NASH | LiverUnited States
-
University of California, San DiegoDaiichi Sankyo, Inc.CompletedNonalcoholic SteatohepatitisUnited States
-
Massachusetts General HospitalRecruitingNASH - Nonalcoholic SteatohepatitisUnited States
-
Meridian Bioscience, Inc.Bristol-Myers SquibbCompletedNASH - Nonalcoholic SteatohepatitisUnited States
-
Gilead SciencesCompletedNonalcoholic Steatohepatitis (NASH)United States
-
Navidea BiopharmaceuticalsCompletedNonalcoholic Steatohepatitis | NASH - Nonalcoholic SteatohepatitisUnited States
-
Milton S. Hershey Medical CenterNoom Inc.CompletedNon-alcoholic SteatohepatitisUnited States
-
University of VirginiaNational Center for Complementary and Integrative Health (NCCIH)CompletedFatty Liver | Non-alcoholic SteatohepatitisUnited States
-
Axcella Health, IncCompleted
-
Conatus Pharmaceuticals Inc.CompletedNon-alcoholic Fatty Liver Disease | Nonalcoholic SteatohepatitisUnited States
-
Eli Lilly and CompanyCompletedNonalcoholic SteatohepatitisUnited States, Spain, Japan, United Kingdom, Belgium, France, Italy, Israel, Mexico, Poland
-
Mayo ClinicCompletedNon Alcoholic Fatty Liver Diseases (NAFLD)United States
-
University of LiverpoolRecruitingHeart Failure | Obstructive Sleep Apnea | Type 2 Diabetes | Pre Diabetes | Non-Alcoholic Fatty Liver DiseaseUnited Kingdom
-
University of OklahomaNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)RecruitingObesity | Nonalcoholic Steatohepatitis | Nonalcoholic Fatty LiverUnited States
-
University of North Carolina, Chapel HillNational Institute of General Medical Sciences (NIGMS)CompletedNon-alcoholic SteatohepatitisUnited States
-
Merck Sharp & Dohme LLCRecruitingHepatic Impairment | Non-alcoholic SteatohepatitisUnited States
-
George Washington UniversityCompletedPsoriasis | Nonalcoholic Fatty Liver DiseaseUnited States
-
Medical College of WisconsinWithdrawnNon-Alcoholic SteatohepatitisUnited States
-
Enanta Pharmaceuticals, IncCovanceCompletedNASH - Nonalcoholic SteatohepatitisUnited States
-
Enanta Pharmaceuticals, IncCompletedNASH - Nonalcoholic SteatohepatitisUnited States
-
National Human Genome Research Institute (NHGRI)TerminatedLiver Cirrhosis | Non-Alcoholic Fatty Liver Disease | Non-Alcoholic Steato-HepatitisUnited States
-
Northwell HealthTerminatedNon-Alcoholic Fatty Liver Disease | Probiotics MeSH Descriptor Data 2018 | Interleukin-17 MeSH Descriptor Data 2018United States